Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jan 15;109(1):9-15.
doi: 10.1007/BF00230868.

Dipyridamole stimulates types II cAMP-dependent protein kinase in vitro

J S Jiménez  1 , C G Lechuga, G Alonso, M J Benítez, M Ros, F J Moreno
Affiliations

Dipyridamole stimulates types II cAMP-dependent protein kinase in vitro

J S Jiménez et al. Mol Cell Biochem. .

Abstract

Dipyridamole activates in vitro type II cAMP-dependent protein kinase. This agent stimulates the autophosphorylation of the regulatory subunit in the presence of cAMP but not so in the absence of the cyclic nucleotide. The activation was also observed with exogenous substrates such as casein, histone 2A and MAP2. This stimulation did not seem to be related to the cAMP binding to the R II subunit of the enzyme. Competition binding experiments showed that dipyridamole does not compete with adenosine for the A1 receptor. The results suggest that the reported regulatory properties of dipyridamole on lipid metabolism (González-Nicolás et al. Int J Biochem 21: 883-888, 1989) might be mediated through a direct action--an activation--on the catalytic subunit of a cAMP-dependent protein kinase.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. J Biol Chem. 1976 Dec 10;251(23):7526-9 - PubMed
    1. Eur J Biochem. 1974 Aug 1;46(3):537-45 - PubMed
    1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1973 Mar;70(3):765-8 - PubMed
    1. Methods Enzymol. 1974;38:49-61 - PubMed

Publication types